Cardinal Health (NYSE:CAH) Beats Q4 Sales Targets
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, ...
Cardinal Health’s Strong Performance and Strategic Acquisitions Justify Buy Rating
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Hosted on MSN1d
Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cardinal Health (CAH) reported $55.26 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 3.8%. EPS of $1.93 for the same period compares to $1.82 a year ...
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
Cardinal Health's second-quarter fiscal 2025 results benefit from solid Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
Seeking Alpha2d
CAH Cardinal Health, Inc.
View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.
Morningstar1d
Cardinal Health Inc CAH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Cardinal Health (NYSE:CAH – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from $127.00 to $135.00 in a research note issued on Wednesday,Benzinga ...